DUBLIN, Aug. 21, 2017 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has received final approval from the U.S. Food & Drug Administration for the store brand OTC ...

Option to swallow an oral suspension of Nexium or to have it administered via a stomach tube now availble. AstraZeneca’s Nexium For Delayed-Release Oral Suspension has been approved for the treatment ...

WILMINGTON, Del., July 15, 2013 /PRNewswire/ -- Acid reflux disease, also known as gastroesophageal reflux disease (GERD), is one of the most common chronic illnesses in the US today, affecting more ...

March 22nd, 2006 – Wilmington, DE – Results from two clinical trials, to be published in the April 2006 edition of the American Journal of Gastroenterology, indicate that NEXIUM® (esomeprazole ...

ROCKVILLE, Md. The Food and Drug Administration on Thursday approved prescription Nexium for short-term use in children ages 1-to-11 years for the treatment of gastroesophageal reflux disease in two ...

DUBLIN, Sept. 27, 2017 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced it has initiated shipments to retail customers of the first-to-market over-the-counter ("OTC") store brand ...

Nexium Control Esomeprazole Impulses are used for the large-term treatment of symptoms associated with reflux such as moving and acid indigestion. The presence of esomeprazole concerns the amount of ...

Los Angeles, CA – New clinical data demonstrated, for the first time in a prospective study, a direct relationship between controlling gastric (or stomach) acid and healing erosive esophagitis caused ...

FILE PHOTO - A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014.REUTERS/Phil Noble LONDON (Reuters) - AstraZeneca (AZN.L) said it would sell the European ...

* ‍Reached settlement of patent litigation with Astrazeneca allowing store brand OTC equivalent of Nexium 24hr capsules to launch in late Sept. Source text for Eikon: Further company coverage: ...